concept

CRYPTIC SPLICING

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CRYPTIC SPLICING: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

25Connections

0Hypotheses

1Analyses

5Outgoing

20Incoming

0Experiments

2Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	CRYPTIC SPLICING

Pathway Diagram

graph TD
    CRYPTIC_SPLICING["CRYPTIC SPLICING"]
    CRYPTIC_SPLICING -->|"contributes to"| Neurodegeneration["Neurodegeneration"]
    TDP_LOF["TDP-LOF"] -->|"causes"| CRYPTIC_SPLICING
    TARDBP["TARDBP"] -->|"mediates"| CRYPTIC_SPLICING
    TDP43["TDP43"] -->|"inhibits"| CRYPTIC_SPLICING
    Antisense_Oligonucleotides["Antisense Oligonucleotides"] -->|"inhibits"| CRYPTIC_SPLICING
    TDP_43["TDP-43"] -->|"causes"| CRYPTIC_SPLICING
    TDP_REG["TDP-REG"] -->|"targets"| CRYPTIC_SPLICING

Outgoing (5)

Target	Relation	Type	Str
Amyotrophic Lateral Sclerosis	biomarker_for	disease	0.90
Frontotemporal Dementia	biomarker_for	disease	0.90
PKN1-N207	associated_with	protein	0.90
Neurodegeneration	contributes_to	phenotype	0.85
ATG4B	associated_with	gene	0.80

Incoming (20)

Source	Relation	Type	Str
TDP-LOF	causes	mechanism	0.95
TDP-43	regulates	protein	0.95
TARDBP	mediates	protein	0.92
TDP43	inhibits	protein	0.90
TARDBP	regulates	protein	0.90
TDP-REG	targets	mechanism	0.90
TARDBP	inhibits	protein	0.90
Antisense Oligonucleotides	inhibits	drug	0.90
TDP-43	causes	protein	0.90
C9ORF72	contributes_to	gene	0.88
TDP-43/Raver1 Fusion Protein	treats	protein	0.88
TDP-43	mediates	protein	0.88
TDP-43	inhibits	protein	0.88
TDP-43 Aggregates	mediates	protein	0.88
UNC13A	involved_in	gene	0.85
Splicenouveau Algorithm	associated_with	mechanism	0.85
RNA-Binding Proteins	regulates	protein	0.85
TDP-43 Cytoplasmic Aggregates	mediates	compound	0.85
ATG4B	involved_in	protein	0.80
dual-guide Cas13	inhibits	drug	0.70

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Cas13 gRNA Design for Silencing MAPT (Tau) Transcripts in Alzheimer's Disease

neurodegeneration | 2026-04-16 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (2)

Multi-agent debates referencing this entity

Can optimized Cas13 guide RNAs selectively silence pathogenic MAPT splice varian

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

Is Cas13-based 4R-tau silencing feasible given collateral cleavage risks in post

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Related Research

Hypotheses and analyses mentioning CRYPTIC SPLICING in their description or question text

No additional research found